Gapping up
In reaction to earnings/guidance:
- HUBG +16.3%, LNTH +14.2%, MHK +13.7%, NOV +8.8%, FBHS +7.7% (also to split into two publicly traded cos), FIVN +7.2%, AEM +7%, BZH +6.9%, WETF +6.1%, WIRE +6%, ROKU +4.8%, TEX +4.4%, NVO +4.4%, MITK +4.3%, TFII +4.2%, MERC +4.2%, AVTR +4.1%, SYNH +4.1%, COOP +3.9%, LTC +3.6%, SLCA +3.6%, CAMP +3%, OMF +3%, FTAI +3%, CE +2.5%, PSO +2.5%, LYB +2.5%, CSL +2.4%, LNT +2.3%, PEGA +2.2%, OLN +2.2% (also to partner with PLUG for green hydrogen), HON +2%, SXT +2%, BIO +1.9%, DLR +1.7%, X +1.7%, KLAC +1.6%, ULCC +1.5%, ZEN +1.4%, CRI +1.2%, SWN +1.1%
Other news:
- GTYH +119.1% (entered into a definitive agreement to be acquired by GI Partners )
- FNCH +54.3% (announces removal of FDA clinical hold on CP101 IND)
- ZYME +43.3% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
- NARI +7% (to join S&P MidCap 400)
- CVGI +6.8% (reaches mutual pricing agreement with top two customers)
- TPH +6.5% (to move to S&P SmallCap 600 from S&P MidCap 400)
- MNTS +5.9% (received a license from the FCC supporting the inaugural flight of the Vigoride orbital transfer vehicle on the upcoming SpaceX Transporter-5 mission targeted for launch in May 2022)
- IMAB +4.3% (names new COO)
- RWT +3.3% (to acquire Riverbend Funding)
- INFU +2.4% (enters into master service agreement with global healthcare tech co)
- LFG +2.3% (to acquire NextGen Power for $215 mln)
- TECK +1.6% (expects technology transformation initiatives to generate $1.1 bln in annualized benefits)
Analyst comments:
- GO +3.4% (upgraded to Buy from Underperform at BofA Securities)
- FWRD +1% (upgraded to Buy from Hold at Stifel)